Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiotech CE marks HemoStream chronic dialysis catheter

This article was originally published in Clinica

Executive Summary

Angiotech Pharmaceuticals has CE marked its HemoStream chronic dialysis catheter for sale in Europe. The catheter is used for long-term vascular access for haemodialysis, a method of removing waste products from the blood of patients with renal failure. It may also be used for temporary access while more permanent options become ready for use, such as surgically-created arteriovenous fistulas (the preferred access method). HemoStream received US FDA clearance in August 2007. Vancouver, Canada-based Angiotech licensed exclusive worldwide marketing and distribution rights to the catheter from Rex Medical (Conshohocken, Pennsylvania) in April 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel